Breaking News
February 22, 2019 - AbbVie Announces New Drug Application Accepted for Priority Review by FDA for Upadacitinib for Treatment of Moderate to Severe Rheumatoid Arthritis
February 22, 2019 - Nature versus nurture and addiction
February 22, 2019 - New website connects researchers with data experts, resources | News Center
February 22, 2019 - Today’s Concerns About Drug Prices Echo The Past
February 22, 2019 - CT and Doppler equipment have low accuracy in detecting cerebral vasospasm and ischemia
February 22, 2019 - Study finds out similarity in function between healthy retina cell and tumor cell
February 22, 2019 - CWRU awarded NIH grant to identify effective treatments for intimate partner violence
February 22, 2019 - Oncotype DX Not Cost-Effective for Low-Risk Breast Cancer
February 22, 2019 - Scientists discover new type of immune cells that are essential for forming heart valves
February 22, 2019 - Talk About Déjà Vu: Senators Set To Re-Enact Drug Price Hearing Of 60 Years Ago
February 22, 2019 - Genetic defect linked to pediatric liver disease identified
February 22, 2019 - New cellular atlas could provide a deeper insight into blinding diseases
February 22, 2019 - Growing number of cancer survivors, fewer providers point to challenge in meeting care needs
February 22, 2019 - Innovative compound offers a new therapeutic approach to treat multiple sclerosis
February 22, 2019 - $1.5 million grant to develop opioid treatment program for jail detainees
February 22, 2019 - FDA’s new proposed rule would update regulatory requirements for sunscreen products in the U.S
February 22, 2019 - Most Hip, Knee Replacements Last Decades, Study Finds
February 22, 2019 - Wellness problems prevalent among ob-gyn residents
February 22, 2019 - In the Spotlight: “The world is your oyster in geriatrics”
February 22, 2019 - Successful testing of multi-organ “human-on-a-chip” could replace animals as test subjects
February 22, 2019 - Analysis of cervical precancer shows decline in two strains of HPV
February 22, 2019 - Sugary stent eases suturing of blood vessels
February 22, 2019 - From surgery to psychiatry: A medical student reevaluates his motivations
February 22, 2019 - Is New App From Feds Your Answer To Navigating Medicare Coverage? Yes And No
February 22, 2019 - New pacemakers powered by heartbeats could reduce need for surgery
February 22, 2019 - The United States records highest drug overdose death rates
February 22, 2019 - Phase 1 data reinforce safety profile of new drug for treating Duchenne muscular dystrophy
February 22, 2019 - Vitamin D supplementation less effective in the presence of obesity, shows study
February 22, 2019 - CPRIT awards nearly $20 million to The University of Texas MD Anderson Cancer Center
February 22, 2019 - Sarepta Announces FDA Acceptance of Golodirsen (SRP-4053) New Drug Application for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 53
February 22, 2019 - An institutional effort to reduce the amount of opioids prescribed following lumbar surgery
February 22, 2019 - Family-history-based models perform better than non-family-history based models
February 22, 2019 - Failure to take statins leads to higher mortality rates | News Center
February 22, 2019 - New study explains why some patients report phantom sensations after limb amputation
February 22, 2019 - First motor-controlled heart valves implanted by Mainz University Medical Center
February 22, 2019 - Novel preclinical model mimics persistent interneuron loss seen in preterm infants
February 22, 2019 - Global health burden of glaucoma has increased, study reveals
February 22, 2019 - A holistic approach key to minimize treatment complexity in patients with interstitial lung disease
February 22, 2019 - 1 in 10 middle-aged Chinese adults are at high risk for heart disease, finds study
February 22, 2019 - More than half a million breast cancer patient’s lives saved by improvements in treatment
February 22, 2019 - Study finds no evidence that tougher policies prevent teenage cannabis use
February 22, 2019 - New blood test detects genetic disorders in fetuses
February 22, 2019 - Lower Self-Perception Observed in Children With Amblyopia
February 22, 2019 - Up to 15 percent of children have sleep apnea, yet 90 percent go undiagnosed
February 22, 2019 - Rare pulmonary defect prompts parents’ nationwide search for answers | News Center
February 22, 2019 - Lesbian and bisexual women at greater risk of being overweight, study finds
February 22, 2019 - UQ research may explain why vitamin D is essential for brain health
February 22, 2019 - Heart Attacks Rising Among Younger Women
February 22, 2019 - How your smartphone is affecting your relationship
February 22, 2019 - Orthopaedic surgeon receives prestigious award, $10 million grant | News Center
February 22, 2019 - New sepsis test could save thousands of lives
February 22, 2019 - Cervical cancer could be eradicated by 2100
February 21, 2019 - Sustained smoking cessation can lower risk of seropositive RA
February 21, 2019 - Thousands with chronic UTIs are not receiving the treatment they need
February 21, 2019 - Are teens getting high on social media? The surprising study seeking the pot-Instagram link
February 21, 2019 - Stanford expands biobank services | News Center
February 21, 2019 - Scientists identify link between drinking contexts and early onset intoxication among adolescents
February 21, 2019 - Strong social support may reduce cardiovascular disease risk in postmenopausal women
February 21, 2019 - Rapid expansion of interventions could prevent up to 13 million cases of cervical cancer within 50 years
February 21, 2019 - Motif Bio Receives Complete Response Letter From The FDA
February 21, 2019 - Researchers map previously unknown disease in children
February 21, 2019 - A skeptical look at popular diets: Going gluten-free
February 21, 2019 - Podcast: KHN’s ‘What The Health?’ How Safe Are Your Supplements?
February 21, 2019 - Factors associated with increased risk of developing surgical site infections
February 21, 2019 - Anticipatory signals in eye movements can help measure attentive capacity, learning with greater precision
February 21, 2019 - Study explores daily exposure to indoor air pollutants
February 21, 2019 - Evening exercise does not negatively affect sleep, may also reduce hunger
February 21, 2019 - Artificial intelligence technique can be used to identify alcohol misuse in trauma setting
February 21, 2019 - Overweight, obesity in adolescence associated with increased risk of renal cancer later in life
February 21, 2019 - BGU develops new AI platform for monitoring and predicting ALS progression
February 21, 2019 - Researchers discover a new promising target to improve HIV vaccines
February 21, 2019 - Brief Anesthesia in Infancy Does Not Mar Neurodevelopment
February 21, 2019 - Gaming system helps with autism diagnosis
February 21, 2019 - Heart Disease: Six Things Women Should Know
February 21, 2019 - More States Say Doctors Must Offer Overdose Reversal Drug Along With Opioids
February 21, 2019 - Researchers explore case studies focused on industries that kill more people than employed
February 21, 2019 - Only half of GP practice buildings are fit for purpose
February 21, 2019 - Intense exercise, fasting and hormones can enhance waste-protein removal, study shows
February 21, 2019 - Scientists can monitor brain activity to predict epileptic seizures few minutes in advance
February 21, 2019 - Study quantifies hepatic and intestinal mRNA expression of Ugt isoforms in rats
Governments across Europe respond in very different ways to lung cancer

Governments across Europe respond in very different ways to lung cancer

image_pdfDownload PDFimage_print

The World Health Organization estimates 387,913 Europeans will die of lung cancer in 2018. The preliminary findings from a new study by the Economist Intelligence Unit comparing 13 countries show that governments across Europe are responding in very different ways to the disease. Countries with better outcomes seem to have effective prevention policies in place and prioritize timely access to new, innovative treatments. Initial research from the study, which will run into early 2019 with in-depth country research and workshops, will be presented today by the Economist Intelligence Unit at the European Cancer Forum in Brussels, which is hosted by MSD. The audience of policy-makers, academics, healthcare professionals, industry, and patient representatives, will provide a first sounding-board for the study findings, and help focus the next phase of research. The EIU will be looking to understand whether countries are advancing, innovating and seizing the opportunities to save lives.

Already, the study points to seven key findings from the 13 countries:

1. For the past 15 years the number of new lung cancer cases has been highest in the Netherlands and lowest in Sweden. The number of deaths caused by lung cancer is highest in Poland, the Netherlands, Belgium, the United Kingdom and Greece – but the numbers have gone down significantly in the past 15 years. Finland has made great progress, and now has the lowest death rate. All other countries have made little to no progress in the past 15 years.

2. We have seen an average increase in the percentage of patients who are still alive 5 years after diagnosis, from 12 percent to only 17 percent over 15 years. The average survival rate for all cancers combined is 50-60 percent.3 Austria, Sweden and Norway have the highest survival rates for lung cancer, with the lowest survival rates occurring in Romania, Finland and the United Kingdom.

3. Lung cancer is a strategic priority in those countries with (lung) cancer control plans and guidelines: Sweden and France score best here, while Finland has some catching up to do.

4. Since smoking is the primary risk factor for lung cancer, with around 80 percent of lung cancers linked to smoking, public health programs around tobacco control and smoking cessation, including regulation of e-cigarettes, are particularly important. The study shows that Finland and Norway lead in this area, while Romania has litte in place.

5. In terms of treatment, the study notes whether patients are getting treatment, tumour testing is available and reimbursed, and new, innovative medicines are reimbursed. Of the four most commonly used biomarkers for lung cancer, testing for all four is only reimbursed in a minority of countries.

6. Only Sweden and Poland have a specific lung cancer plan/section of the National Cancer Control Plan (NCCP), and only four countries (Austria, France, Romania and Greece) have updated their NCCP in the last five years.

7. Only half of the countries (Belgium, France, Germany, Netherlands, Poland,Spain, UK) have started or are involved in a trial to investigate whether or how screening could be introduced.

Giving his reaction ahead of his keynote speech at the European Cancer Forum, Martin Seychell, Deputy Director-General in the Health and Food Safety Directorate General (DG SANTE) of the European Commission, said: “In recent years we have been able to improve outcomes for cancer patients, although cancer remains the second-highest cause of death in the EU”. He added that “The results of the Economist Intelligence Unit study clearly show the need for close collaboration between all stakeholders and fighting this disease will undoubtedly remain a priority for the Commission in the years to come.”

“The country benchmarking and in country analyses in this study point us in the direction of how to achieve better outcomes,” said Alfonso Aguarón on behalf of Lung Cancer Europe. “Policy makers should see these results and be encouraged to take the findings of the report forward. It is time for more awareness around the burden of this disease for patients, their family and friends. It is about time these patients get noticed.”

Deepak Khanna, Senior Vice President and Regional President, EMEAC Oncology for MSD, commented: “All stakeholders should accelerate implementing policies which contribute to better outcomes. As a biopharmaceutical research company, we are working with governments across Europe to ensure patients have timely access to our innovative cancer medicines, to help extend and improve the lives of patients with lung cancer.”

Tagged with:

About author

Related Articles